Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-12-14
1996-01-16
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 86, 514 89, 514326, 514341, 514365, 514372, 514374, 514378, 514383, 514385, 514381, 514397, 544243, 544298, 544333, 546 21, 546210, 546278, 548112, 548202, 548203, 548204, 548205, 548146, 548215, 548225, 548233, 548235, 548240, 548243, 548245, 548247, 548248, 548250, 548251, 548252, 548253, 548254, 548255, 5482622, 5482668, 5482672, 5482676, 5482678, 5483144, 5483225, 5483265, 5483351, 5483381, 5483411, 5483415, 5483421, 5483425, 5483435, 5483461, C07F 902, C07D23110
Patent
active
054847800
ABSTRACT:
This invention provides novel phenyl and heterocyclic derivatives, their pharmaceutical formulations and their methods of use for antagonizing angiotensin II receptors in mammals.
REFERENCES:
patent: 3737422 (1973-06-01), Fluoret
patent: 3772315 (1973-11-01), Regel et al.
patent: 3872121 (1975-03-01), Kummer et al.
patent: 4089962 (1978-05-01), Harrison et al.
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4299769 (1981-11-01), McEvoy et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4379927 (1983-04-01), Vorbruggen et al.
patent: 4448781 (1984-05-01), Cross et al.
patent: 4528195 (1985-07-01), Thorogood
patent: 4582847 (1986-04-01), Furukawa et al.
patent: 4584383 (1986-04-01), Pharhi
patent: 4880804 (1989-11-01), Carini et al.
patent: 4908363 (1990-03-01), Klotzer et al.
patent: 4916129 (1990-04-01), Carini et al.
patent: 4962120 (1990-10-01), Bailey et al.
patent: 5053329 (1991-10-01), Chen et al.
patent: 5064825 (1991-11-01), Chakravarty et al.
patent: 5073566 (1991-12-01), Lifer et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5102903 (1992-04-01), Smith
patent: 5151497 (1992-09-01), Hchida et al.
patent: 5173494 (1992-12-01), Chiu et al.
patent: 5175164 (1992-12-01), Bagley et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5180724 (1993-01-01), Bowles et al.
patent: 5183810 (1993-02-01), Greenlee et al.
patent: 5185351 (1993-02-01), Finkelstein et al.
patent: 5210211 (1993-05-01), Hodges et al.
patent: 5234917 (1993-08-01), Finkelstein et al.
CA 112:98527f Preparation . . . function. Kihara et al., p. 752, 1990.
CA 114:164227c Preparation . . . antiarrhythmics. Bailey et al., p. 779, 1991.
Wong, et al., J. Pharm Exptl. Ther., 247 (1), 1 (1988).
Danishefsky, et al., J. Org. Chem., 42 (10) 1821-1823 (1977).
Boyd Donald B.
Hauser Kenneth L.
Lifer Sherryl L.
Marshall Winston S.
Palkowitz Alan D.
Boone David E.
Caltrider Steven P.
Eli Lilly and Company
McKane Joseph K.
Strode Janelle D.
LandOfFree
Angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309482